BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22344476)

  • 21. Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein.
    Abedini MR; Muller EJ; Bergeron R; Gray DA; Tsang BK
    Oncogene; 2010 Jan; 29(1):11-25. PubMed ID: 19802016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins.
    Horibe S; Matsuda A; Tanahashi T; Inoue J; Kawauchi S; Mizuno S; Ueno M; Takahashi K; Maeda Y; Maegouchi T; Murakami Y; Yumoto R; Nagai J; Takano M
    Life Sci; 2015 Mar; 124():31-40. PubMed ID: 25625243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin.
    Chen X; Jiang Y; Huang Z; Li D; Chen X; Cao M; Meng Q; Pang H; Sun L; Zhao Y; Cai L
    Sci Rep; 2016 Jan; 6():19455. PubMed ID: 26781643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schedule-dependent reversion of cisplatin resistance by 5-fluorouracil in a cisplatin-resistant human lung adenocarcinoma cell line A549DDP.
    Zhan M; Liu X
    Chin Med J (Engl); 1999 Apr; 112(4):336-9. PubMed ID: 11593534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The E3 ubiquitin ligase CHIP selectively regulates mutant epidermal growth factor receptor by ubiquitination and degradation.
    Chung C; Yoo G; Kim T; Lee D; Lee CS; Cha HR; Park YH; Moon JY; Jung SS; Kim JO; Lee JC; Kim SY; Park HS; Park M; Park DI; Lim DS; Jang KW; Lee JE
    Biochem Biophys Res Commun; 2016 Oct; 479(2):152-158. PubMed ID: 27475501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells.
    Zhao Z; Zhang L; Yao Q; Tao Z
    Cancer Gene Ther; 2015 Apr; 22(3):108-14. PubMed ID: 25721211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative Proteomic Analysis of Human Lung Adenocarcinoma Cisplatin-resistant Cell Strain A549/CDDP.].
    Shi S; Wang J; Zhai W; Gao G; Tang J; Fan K; Tang Z; Wei L
    Zhongguo Fei Ai Za Zhi; 2009 Nov; 12(11):1155-8. PubMed ID: 20723362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [RNA Interference targeting GRP75 decreases cisplatin resistance in human lung adenocarcinoma cell].
    Shi S; He Z; Cai J; Qiu J
    Zhongguo Fei Ai Za Zhi; 2011 Apr; 14(4):305-10. PubMed ID: 21496427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
    Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
    Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome.
    Matsunaga T; Yamaji Y; Tomokuni T; Morita H; Morikawa Y; Suzuki A; Yonezawa A; Endo S; Ikari A; Iguchi K; El-Kabbani O; Tajima K; Hara A
    Free Radic Res; 2014 Nov; 48(11):1371-85. PubMed ID: 25156503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased phosphorylation of nuclear phosphoproteins in human lung-cancer cells resistant to cis-diamminedichloroplatinum (II).
    Nishio K; Sugimoto Y; Kasahara K; Fujiwara Y; Nishiwaki S; Fujiki H; Ohata M; Saijo N
    Int J Cancer; 1992 Feb; 50(3):438-42. PubMed ID: 1310490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells].
    He J; Song X; Yu L; Li J; Qiao Z; Jiu R; Yu B; Liu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):625-9. PubMed ID: 25940289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differential proteomic analysis of drug resistant A549/DDP cell lines in human lung adenocarcinoma].
    Wei R; Xie Y; Yang D; He L; Peng F; Sheng L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 35(8):854-60. PubMed ID: 20818079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.
    Zhu W; Shan X; Wang T; Shu Y; Liu P
    Int J Cancer; 2010 Dec; 127(11):2520-9. PubMed ID: 20162574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
    Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of Extracellular Vesicles on the Drug Resistance of Lung Adenocarcinoma Cells by Modulating the ATP Binding Cassette Transporter G2].
    Wang L; Mi Y; Zhang XF; Li X; He CY; Li C; Liu L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 May; 53(3):452-456. PubMed ID: 35642154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
    Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J
    PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase in resistance to anticancer drugs involves occludin in spheroid culture model of lung adenocarcinoma A549 cells.
    Eguchi H; Akizuki R; Maruhashi R; Tsukimoto M; Furuta T; Matsunaga T; Endo S; Ikari A
    Sci Rep; 2018 Oct; 8(1):15157. PubMed ID: 30310131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
    Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
    BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative Proteomic Analysis of Cellular Resistance to the Nanoparticle Abraxane.
    Zhao M; Li H; Bu X; Lei C; Fang Q; Hu Z
    ACS Nano; 2015 Oct; 9(10):10099-112. PubMed ID: 26324059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.